Publicaciones en colaboración con investigadores/as de University Medical Center Freiburg (28)

2024

  1. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

    Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 1, pp. 275-286.e18

  2. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

2023

  1. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 984-996.e10

  2. Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium

    PLoS ONE, Vol. 18, Núm. 1 January

  3. Cerebral Oximetry Monitoring in Extremely Preterm Infants

    New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511

  4. Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine

    The Lancet Oncology

  5. Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study

    eClinicalMedicine, Vol. 55

  6. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095

  7. Potential pitfalls in the use of real-world data for studying long COVID

    Nature Medicine

  8. Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 5, pp. 1391-1401.e7

2022

  1. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients

    Journal of Clinical Immunology, Vol. 42, Núm. 8, pp. 1748-1765

  2. International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality

    npj Digital Medicine, Vol. 5, Núm. 1

2021

  1. Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study

    BMJ Open Respiratory Research, Vol. 8, Núm. 1

  2. Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

    BMC Medical Research Methodology, Vol. 21, Núm. 1

  3. Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

    Frontiers in Pediatrics, Vol. 9

  4. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

    Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5

  5. MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase

    Brain, Vol. 144, Núm. 9, pp. 2722-2731

2020

  1. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

    Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 4, pp. 901-911

2019

  1. Correction to: Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group (Journal of Clinical Immunology, (2019), 39, 1, (45-54), 10.1007/s10875-018-0577-9)

    Journal of Clinical Immunology

  2. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group

    Journal of Clinical Immunology, Vol. 39, Núm. 1, pp. 45-54